Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ IgG positive 88% Improvement Relative Risk Vitamin D for COVID-19  De Nicolò et al.  Prophylaxis Is prophylaxis with vitamin D beneficial for COVID-19? Prospective study of 106 patients in Italy (January - April 2021) Lower IgG positivity with vitamin D (p=0.002) c19early.org De Nicolò et al., Nutrients, December 2022 Favors vitamin D Favors control

Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease

De Nicolò et al., Nutrients, doi:10.3390/nu15010169
Dec 2022  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,200+ studies for 70+ treatments. c19early.org
Prospective study of 106 IBD patients in Italy, showing lower risk of IgG positivity with vitamin D supplementation. Vitamin D levels below 30 ng/mL were associated with a higher probability of symptomatic cases.
This is the 104th of 120 COVID-19 controlled studies for vitamin D, which collectively show efficacy with p<0.0000000001 (1 in 248 sextillion).
29 studies are RCTs, which show efficacy with p=0.0000024.
risk of IgG positive, 88.4% lower, OR 0.12, p = 0.002, treatment 43, control 63, adjusted per study, multivariable, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
De Nicolò et al., 29 Dec 2022, prospective, Italy, peer-reviewed, 11 authors, study period January 2021 - April 2021, dosage not specified. Contact: amedeo.denicolo@unito.it (corresponding author).
This PaperVitamin DAll
Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease
Amedeo De Nicolò, Jessica Cusato, Cristina Bezzio, Simone Saibeni, Marta Vernero, Michela Disabato, Gian Paolo Caviglia, Alice Ianniello, Alessandra Manca, Antonio D’avolio, Davide Giuseppe Ribaldone
Nutrients, doi:10.3390/nu15010169
The coronavirus disease (COVID-19) pandemic represents a global health challenge, particularly considering concomitant diseases. Patients with inflammatory bowel diseases (IBD) can be considered a population at risk. On the other hand, the risk of developing IBD and COVID-19 have both been described as modulated by vitamin D (VD) levels. In this work, a cohort of 106 adult patients affected by IBD was prospectively enrolled, during the second wave of the pandemic in Italy. In these patients, VD plasma levels, demographic, and clinical characteristics were tested for a correlation/an association with the risk of infection with SARS-CoV-2 in the study period (antispike IgG positivity) and the severity of COVID-19 symptoms. By multivariate logistic regression analysis, VD supplementation (Odds Ratio; OR 0.116, p = 0.002), therapy with monoclonal antibodies (OR 0.227, p = 0.007), and the use of mesalazine (OR 2.968, p = 0.046) were found to be independent predictors of SARS-CoV-2 positivity. Moreover, hypertension was associated with severe disease (p = 0.019), while a VD level higher than 30 ng/mL (p = 0.031, OR 0.078) was associated with asymptomatic infection. No interplay between IBD activity and COVID-19 risk of infection or symptoms was observed. These results confirm the importance of VD levels in defining the risk of COVID-19 and give encouraging data about the safety of maintaining immunomodulatory treatments for IBD during the COVID-19 pandemic.
Conflicts of Interest: The authors declare no conflict of interest.
References
Anbarcioglu, Kirtiloglu, Ozturk, Kolbakir, Acikgoz et al., Vitamin D deficiency in patients with aggressive periodontitis, Oral Dis, doi:10.1111/odi.12968
Arboleda, Urcuqui-Inchima, Vitamin, Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics? Front, Immunol, doi:10.3389/fimmu.2020.01523
Arora, Patel, Nicol, Field, Restori et al., Vitamin D and the Ability to Produce 1,25(OH)(2)D Are Critical for Protection from Viral Infection of the Lungs, Nutrients, doi:10.3390/nu14153061
Azrielant, Shoenfeld, Vitamin D and the Immune System, Isr. Med. Assoc. J
Balestrieri, Ribolsi, Guarino, Emerenziani, Altomare et al., Nutritional Aspects in Inflammatory Bowel Diseases, Nutrients, doi:10.3390/nu12020372
Benskin, A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency, Front. Public Health, doi:10.3389/fpubh.2020.00513
Bezzio, Armuzzi, Furfaro, Ardizzone, Milla et al., Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: An IG-IBD study, Aliment. Pharmacol. Ther, doi:10.1111/apt.16663
Bezzio, Saibeni, Variola, Allocca, Massari et al., Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study, Gut, doi:10.1136/gutjnl-2020-321411
Boglione, Cusato, De Nicolo, Cariti, Di Perri et al., Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon, J. Viral Hepat, doi:10.1111/jvh.12288
Calcagno, Ghisetti, Emanuele, Trunfio, Faraoni et al., Risk for SARS-CoV-2 Infection in Healthcare Workers, Emerg. Infect. Dis, doi:10.3201/eid2701.203027
Cascella, Rajnik, Aleem, Dulebohn, Di Napoli et al., Evaluation, and Treatment of Coronavirus (COVID-19
Castillo, Entrenas Costa, Vaquero Barrios, Alcala Diaz, Lopez Miranda et al., Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J. Steroid Biochem. Mol. Biol, doi:10.1016/j.jsbmb.2020.105751
Chauss, Freiwald, Mcgregor, Yan, Wang et al., Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells, Nat. Immunol, doi:10.1038/s41590-021-01080-3
Coperchini, Ricci, Croce, Denegri, Ruggiero et al., Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: A pilot study, Endocrine, doi:10.1007/s12020-021-02807-w
Courbebaisse, Cavalier, Vitamin, in 2020: An Old Pro-Hormone with Potential Effects beyond Mineral Metabolism, Nutrients, doi:10.3390/nu12113378
Cusato, Allegra, Boglione, De Nicolo, Baietto et al., Vitamin D pathway gene variants and HCV-2/3 therapy outcomes, Antivir. Ther, doi:10.3851/IMP2853
D'avolio, Avataneo, Manca, Cusato, De Nicolo et al., 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2, Nutrients, doi:10.3390/nu12051359
De Nicolò, Avataneo, Cusato, Palermiti, Mula et al., Analytical Validation and Clinical Application of Rapid Serological Tests for SARS-CoV-2 Suitable for Large-Scale Screening, Diagnostics, doi:10.3390/diagnostics11050869
Dickie, Church, Coulthard, Mathews, Emery et al., Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes, Rheumatology, doi:10.1093/rheumatology/keq124
Dipasquale, Lo Presti, Milani, Corsello, Agostoni et al., Vitamin D in Prevention of Autoimmune Diseases, Front. Biosci. Landmark, doi:10.31083/j.fbl2710288
Dragasevic, Stankovic, Kotur, Milutinovic, Milovanovic et al., Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease, Life, doi:10.3390/life12101623
Ecco, Update on COVID-19 and IBD
Gallelli, Mannino, Luciani, De Sire, Mancuso et al., Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice Study, Nutrients, doi:10.3390/nu13113932
Gibbons, Norton, Mccullough, Meltzer, Lavigne et al., Association between vitamin D supplementation and COVID-19 infection and mortality, Sci. Rep, doi:10.1038/s41598-022-24053-4
Holick, Binkley, Bischoff-Ferrari, Gordon, Hanley et al., Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline, J. Clin. Endocrinol. Metab, doi:10.1210/jc.2011-0385
Holick, The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention, Rev. Endocr. Metab. Disord, doi:10.1007/s11154-017-9424-1
Huang, Lian, Song, Ma, Lian et al., Clinical features of severe patients infected with 2019 novel coronavirus: A systematic review and meta-analysis, Ann. Transl. Med, doi:10.21037/atm-20-2124
Jain, Chaurasia, Sengar, Singh, Mahor et al., Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers, Sci. Rep, doi:10.1038/s41598-020-77093-z
Jin, Lian, Hu, Gao, Zheng et al., Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms, Gut, doi:10.1136/gutjnl-2020-320926
Katz, Yue, Xue, Increased risk for COVID-19 in patients with vitamin D deficiency, Nutrition, doi:10.1016/j.nut.2020.111106
Kolls, Garry, Role of the T cell vitamin D receptor in severe COVID-19, Nat. Immunol, doi:10.1038/s41590-021-01098-7
Lu, Clinical presentations of inflammatory bowel disease: East meets West, J. Chin. Med. Assoc, doi:10.1016/j.jcma.2016.09.005
Maaser, Sturm, Vavricka, Kucharzik, Fiorino et al., ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications, J. Crohns Colitis, doi:10.1093/ecco-jcc/jjy113
Maghbooli, Sahraian, Ebrahimi, Pazoki, Kafan et al., Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection, PLoS ONE, doi:10.1371/journal.pone.0239799
Martineau, Cantorna, Vitamin D for COVID-19: Where are we now?, Nat. Rev. Immunol, doi:10.1038/s41577-022-00765-6
Martineau, Vitamin D in the prevention or treatment of COVID-19, Proc. Nutr. Soc, doi:10.1017/S0029665122002798
Matheu, Back, Mondoc, Issazadeh-Navikas, Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: Enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease, J. Allergy Clin. Immunol, doi:10.1016/s0091-6749
Mehta, Gracias, Croft, TNF activity and T cells, Cytokine, doi:10.1016/j.cyto.2016.08.003
Meltzer, Best, Zhang, Vokes, Arora et al., Association of Vitamin D Status and Other Clinical Characteristics with COVID-19 Test Results, JAMA Netw. Open, doi:10.1001/jamanetworkopen.2020.19722
Munshi, Hussein, Toraih, Elshazli, Jardak et al., Vitamin D insufficiency as a potential culprit in critical COVID-19 patients, J. Med. Virol, doi:10.1002/jmv.26360
Murai, Fernandes, Antonangelo, Gualano, Pereira, Effect of a Single High-Dose Vitamin D3 on the Length of Hospital Stay of Severely 25-Hydroxyvitamin D-Deficient Patients with COVID-19, Clinics, doi:10.6061/clinics/2021/e3549
Murai, Fernandes, Sales, Pinto, Goessler et al., Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial, JAMA, doi:10.1001/jama.2020.26848
Neurath, COVID-19 and immunomodulation in IBD, Gut, doi:10.1136/gutjnl-2020-321269
Sanson, De Nicolo, Zerbato, Segat, Koncan et al., A combined role for low vitamin D and low albumin circulating levels as strong predictors of worse outcome in COVID-19 patients, Ir. J. Med. Sci, doi:10.1007/s11845-022-02952-9
Sekine, Perez-Potti, Rivera-Ballesteros, Stralin, Gorin et al., Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19, Cell, doi:10.1016/j.cell.2020.08.017
Siew, Hilmi, Blake, Bhayat, Adsul et al., Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting, Inflamm. Bowel Dis, doi:10.1093/ibd/izy153
Vatn, Sandvik, Inflammatory bowel disease, Scand. J. Gastroenterol, doi:10.3109/00365521.2015.1033000
Villasis-Keever, Lopez-Alarcon, Miranda-Novales, Zurita-Cruz, Barrada-Vazquez et al., Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial, Arch. Med. Res, doi:10.1016/j.arcmed.2022.04.003
Wang, Wang, Li, Chen, Han et al., Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone, ACS Infect. Dis, doi:10.1021/acsinfecdis.1c00096
Wong, Lui, Sung, Covid-19 and the digestive system, J. Gastroenterol. Hepatol, doi:10.1111/jgh.15047
Wu, Chen, Cai, Xia, Zhou et al., Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China, JAMA Intern. Med, doi:10.1001/jamainternmed.2020.0994
Wu, Liu, Deng, The Role of Vitamin D in Immune System and Inflammatory Bowel Disease, J. Inflamm. Res, doi:10.2147/JIR.S363840
Zhang, Leung, Richers, Liu, Remigio et al., Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1, J. Immunol, doi:10.4049/jimmunol.1102412
Zhang, Wu, Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis, Neurosci. Bull, doi:10.1007/s12264-010-0731-8
Zhao, Zhang, Wu, Li, Liu et al., Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice, BMC Gastroenterol, doi:10.1186/1471-230X-12-57
Zurita-Cruz, Fonseca-Tenorio, Villasis-Keever, Lopez-Alarcon, Parra-Ortega et al., Efficacy and safety of vitamin D supplementation in hospitalized COVID-19 pediatric patients: A randomized controlled trial, Front. Pediatr, doi:10.3389/fped.2022.943529
{ 'DOI': '10.3390/nu15010169', 'ISSN': ['2072-6643'], 'URL': 'http://dx.doi.org/10.3390/nu15010169', 'abstract': '<jats:p>The coronavirus disease (COVID-19) pandemic represents a global health challenge, ' 'particularly considering concomitant diseases. Patients with inflammatory bowel diseases ' '(IBD) can be considered a population at risk. On the other hand, the risk of developing IBD ' 'and COVID-19 have both been described as modulated by vitamin D (VD) levels. In this work, a ' 'cohort of 106 adult patients affected by IBD was prospectively enrolled, during the second ' 'wave of the pandemic in Italy. In these patients, VD plasma levels, demographic, and clinical ' 'characteristics were tested for a correlation/an association with the risk of infection with ' 'SARS-CoV-2 in the study period (anti-spike IgG positivity) and the severity of COVID-19 ' 'symptoms. By multivariate logistic regression analysis, VD supplementation (Odds Ratio; OR ' '0.116, p = 0.002), therapy with monoclonal antibodies (OR 0.227, p = 0.007), and the use of ' 'mesalazine (OR 2.968, p = 0.046) were found to be independent predictors of SARS-CoV-2 ' 'positivity. Moreover, hypertension was associated with severe disease (p = 0.019), while a VD ' 'level higher than 30 ng/mL (p = 0.031, OR 0.078) was associated with asymptomatic infection. ' 'No interplay between IBD activity and COVID-19 risk of infection or symptoms was observed. ' 'These results confirm the importance of VD levels in defining the risk of COVID-19 and give ' 'encouraging data about the safety of maintaining immunomodulatory treatments for IBD during ' 'the COVID-19 pandemic.</jats:p>', 'alternative-id': ['nu15010169'], 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-5973-9948', 'affiliation': [], 'authenticated-orcid': False, 'family': 'De Nicolò', 'given': 'Amedeo De', 'sequence': 'first'}, { 'ORCID': 'http://orcid.org/0000-0003-1977-9694', 'affiliation': [], 'authenticated-orcid': False, 'family': 'Cusato', 'given': 'Jessica', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Bezzio', 'given': 'Cristina', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Saibeni', 'given': 'Simone', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-6904-7638', 'affiliation': [], 'authenticated-orcid': False, 'family': 'Vernero', 'given': 'Marta', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Disabato', 'given': 'Michela', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Caviglia', 'given': 'Gian Paolo', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Ianniello', 'given': 'Alice', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-8540-6709', 'affiliation': [], 'authenticated-orcid': False, 'family': 'Manca', 'given': 'Alessandra', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-1321-4126', 'affiliation': [], 'authenticated-orcid': False, 'family': 'D’Avolio', 'given': 'Antonio', 'sequence': 'additional'}, { 'ORCID': 'http://orcid.org/0000-0002-9421-3087', 'affiliation': [], 'authenticated-orcid': False, 'family': 'Ribaldone', 'given': 'Davide Giuseppe', 'sequence': 'additional'}], 'container-title': 'Nutrients', 'container-title-short': 'Nutrients', 'content-domain': {'crossmark-restriction': False, 'domain': []}, 'created': { 'date-parts': [[2022, 12, 30]], 'date-time': '2022-12-30T08:18:18Z', 'timestamp': 1672388298000}, 'deposited': { 'date-parts': [[2022, 12, 30]], 'date-time': '2022-12-30T08:55:24Z', 'timestamp': 1672390524000}, 'indexed': { 'date-parts': [[2022, 12, 31]], 'date-time': '2022-12-31T06:10:30Z', 'timestamp': 1672467030516}, 'is-referenced-by-count': 0, 'issue': '1', 'issued': {'date-parts': [[2022, 12, 29]]}, 'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2023, 1]]}}, 'language': 'en', 'license': [ { 'URL': 'https://creativecommons.org/licenses/by/4.0/', 'content-version': 'vor', 'delay-in-days': 0, 'start': { 'date-parts': [[2022, 12, 29]], 'date-time': '2022-12-29T00:00:00Z', 'timestamp': 1672272000000}}], 'link': [ { 'URL': 'https://www.mdpi.com/2072-6643/15/1/169/pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'member': '1968', 'original-title': [], 'page': '169', 'prefix': '10.3390', 'published': {'date-parts': [[2022, 12, 29]]}, 'published-online': {'date-parts': [[2022, 12, 29]]}, 'publisher': 'MDPI AG', 'reference-count': 0, 'references-count': 0, 'relation': {}, 'resource': {'primary': {'URL': 'https://www.mdpi.com/2072-6643/15/1/169'}}, 'score': 1, 'short-title': [], 'source': 'Crossref', 'subject': ['Food Science', 'Nutrition and Dietetics'], 'subtitle': [], 'title': 'Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and ' 'COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease', 'type': 'journal-article', 'volume': '15'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit